Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1961 Apr;47(4):512–526. doi: 10.1073/pnas.47.4.512

PURIFICATION AND IMMUNOLOGICAL CHARACTERIZATION OF TYPES 4 AND 5 ADENOVIRUS-SOLUBLE ANTIGENS*

Wesley C Wilcox 1, Harold S Ginsberg 1
PMCID: PMC221481  PMID: 13785230

Full text

PDF
512

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BINN L. N., HILLEMAN M. R., RODRIGUEZ J. E., GLABERE R. R. Antigenic relationships among adenoviruses with appraisal of reliability of complement-fixation test for typing isolates. J Immunol. 1958 Jun;80(6):501–508. [PubMed] [Google Scholar]
  2. BREITENFELD P. M., SCHAFER W. The formation of fowl plague virus antigens in infected cells, as studied with fluorescent antibodies. Virology. 1957 Oct;4(2):328–345. doi: 10.1016/0042-6822(57)90067-3. [DOI] [PubMed] [Google Scholar]
  3. BURNET F. M., LIND P. E. A genetic approach to variation in influenza viruses; recombination of characters between the influenza virus A strain NWS and strains of different serological subtypes. J Gen Microbiol. 1951 Feb;5(1):67–82. doi: 10.1099/00221287-5-1-67. [DOI] [PubMed] [Google Scholar]
  4. BURTON K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956 Feb;62(2):315–323. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DE MARS R. I. The production of phage-related materials when bacteriophage development in interrupted by proflavine. Virology. 1955 May;1(1):83–99. doi: 10.1016/0042-6822(55)90007-6. [DOI] [PubMed] [Google Scholar]
  6. DISCHE Z. Qualitative and quantitative colorimetric determination of heptoses. J Biol Chem. 1953 Oct;204(2):983–997. [PubMed] [Google Scholar]
  7. EVERETT S. F., GINSBERG H. S. A toxin-like material separable from type 5 adenovirus particles. Virology. 1958 Dec;6(3):770–771. doi: 10.1016/0042-6822(58)90123-5. [DOI] [PubMed] [Google Scholar]
  8. FRANKLIN R. M. The synthesis of fowl plague virus products in a proflavine-inhibited tissue culture system. Virology. 1958 Oct;6(2):525–539. doi: 10.1016/0042-6822(58)90099-0. [DOI] [PubMed] [Google Scholar]
  9. Fraenkel-Conrat H., Williams R. C. RECONSTITUTION OF ACTIVE TOBACCO MOSAIC VIRUS FROM ITS INACTIVE PROTEIN AND NUCLEIC ACID COMPONENTS. Proc Natl Acad Sci U S A. 1955 Oct 15;41(10):690–698. doi: 10.1073/pnas.41.10.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. GINSBERG H. S. Characteristics of the new respiratory viruses (adenoviruses). I. Qualitative and quantitative aspects of the neutralization reaction. J Immunol. 1956 Oct;77(4):271–278. [PubMed] [Google Scholar]
  11. GINSBERG H. S. Characteristics on the adenoviruses. III. Reproductive cycle of types 1 to 4. J Exp Med. 1958 Jan 1;107(1):133–152. doi: 10.1084/jem.107.1.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. GINSBERG H. S., DIXON M. K. Deoxyribonucleic acid (DNA) and protein alterations in HeLa cells infected with type 4 adenovirus. J Exp Med. 1959 Apr 1;109(4):407–422. doi: 10.1084/jem.109.4.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. GINSBERG H. S., DIXON M. K. Nucleuc acid synthesis in types 4 and 5 adenovirus-infected HeLa cells. J Exp Med. 1961 Feb 1;113:283–299. doi: 10.1084/jem.113.2.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. GINSBERG H. S., GOLD E., JORDAN W. S., Jr Tryptose phosphate broth as supplementary factor for maintenance of HeLa cell tissue cultures. Proc Soc Exp Biol Med. 1955 May;89(1):66–71. doi: 10.3181/00379727-89-21718. [DOI] [PubMed] [Google Scholar]
  15. GINSBERG H. S. Newer aspects of adenovirus infections. Am J Public Health Nations Health. 1959 Nov;49:1480–1485. doi: 10.2105/ajph.49.11.1480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. HERSHEY A. D. Nucleic acid economy in bacteria infected with bacteriophage T2. J Gen Physiol. 1953 Sep;37(1):1–23. doi: 10.1085/jgp.37.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. HILLEMAN M. R., TOUSIMIS A. J., WERNER J. H. Biophysical characterization of the RI (RI-67) viruses. Proc Soc Exp Biol Med. 1955 Aug;89(4):587–593. doi: 10.3181/00379727-89-21884. [DOI] [PubMed] [Google Scholar]
  18. HILLEMAN M. R., WERNER J. H. Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med. 1954 Jan;85(1):183–188. doi: 10.3181/00379727-85-20825. [DOI] [PubMed] [Google Scholar]
  19. HOYLE L. Structure of the influenza virus; the relation between biological activity and chemical structure of virus fractions. J Hyg (Lond) 1952 Jun;50(2):229–245. doi: 10.1017/s0022172400019562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. KLEMPERER H. G., PEREIRA H. G. Study of adenovirus antigens fractionated by chromatography on DEAE-cellulose. Virology. 1959 Dec;9:536–545. doi: 10.1016/0042-6822(59)90147-3. [DOI] [PubMed] [Google Scholar]
  21. LEDINKO N. Production of noninfectious complement-fixing poliovirus particles in HeLa cells treated with proflavine. Virology. 1958 Oct;6(2):512–524. doi: 10.1016/0042-6822(58)90098-9. [DOI] [PubMed] [Google Scholar]
  22. MURAKAMI W. T., VAN VUNAKIS H., LEVINE L. Synthesis of T2 internal protein in infected Escherichia coli, strain B. Virology. 1959 Dec;9:624–635. doi: 10.1016/0042-6822(59)90153-9. [DOI] [PubMed] [Google Scholar]
  23. PEREIRA H. G. A protein factor responsible for the early cytopathic effect of adenoviruses. Virology. 1958 Dec;6(3):601–611. doi: 10.1016/0042-6822(58)90109-0. [DOI] [PubMed] [Google Scholar]
  24. PEREIRA H. G., ALLISON A. C., FARTHING C. P. Study of adenovirus antigens by immunoelectrophoresis. Nature. 1959 Mar 28;183(4665):895–896. doi: 10.1038/183895a0. [DOI] [PubMed] [Google Scholar]
  25. PEREIRA H. G. Typing of adenoidal-pharyngeal-conjunctival (APC) viruses by complement-fixation. J Pathol Bacteriol. 1956 Jul;72(1):105–109. [PubMed] [Google Scholar]
  26. PHILIPSON L. Separation on DEAE cellulose of components associated with adenovirus reproduction. Virology. 1960 Apr;10:459–465. doi: 10.1016/0042-6822(60)90129-x. [DOI] [PubMed] [Google Scholar]
  27. PILLEMER L., BLUM L., LEPOW I. H., WURZ L., TODD E. W. The properdin system and immunity. III. The zymosan assay of properdin. J Exp Med. 1956 Jan 1;103(1):1–13. doi: 10.1084/jem.103.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. RANDRUP A. Ultracentrifugation of the virus of foot-and-mouth disease. III. Verification of the existence of two particles of different size carrying the complement-fixing antigen. Acta Pathol Microbiol Scand. 1954;34(4):355–365. [PubMed] [Google Scholar]
  29. ROWE W. P., HARTLEY J. W., ROIZMAN B., LEVY H. B. Characterization of a factor formed in the course of adenovirus infection of tissue cultures causing detachment of cells from glass. J Exp Med. 1958 Nov 1;108(5):713–729. doi: 10.1084/jem.108.5.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. STEINMAN H. G., MURTAUGH P. A. Isoelectric precipitation of adenovirus and of its complement-fixing antigen. Virology. 1959 Mar;7(3):291–299. doi: 10.1016/0042-6822(59)90199-0. [DOI] [PubMed] [Google Scholar]
  31. TOOLAN H. W. Transplantable human neoplasms maintained in cortisone-treated laboratory animals: H.S. No. 1; H.Ep. No. 1; H.Ep. No. 2; H.Ep. No. 3; and H.Emb.Rh. No. 1. Cancer Res. 1954 Oct;14(9):660–666. [PubMed] [Google Scholar]
  32. WILDY P., HOLDEN H. F. The complement fixing antigen of herpes simplex virus. Aust J Exp Biol Med Sci. 1954 Oct;32(5):621–632. doi: 10.1038/icb.1954.65. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES